文献速递心律失常

工程化人类心脏组织揭示儿茶酚胺敏感性多形性室速的发病机制

Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue.
PubMed 文献 · Circulation · 2019-07-17

本研究利用诱导多能干细胞来源心肌细胞构建光遗传学工程化人类心肌组织模型,结合基因组编辑技术研究儿茶酚胺敏感性多形性室速(CPVT)的组织水平特性。结果显示,CPVT组织在快速起搏和儿茶酚胺刺激下易发生折返心律,与舒张期Ca2+升高及Ca2+波速度的时空离散度增加有关;Cas9编辑证实Ryanodine受体Ser2814磷酸化是揭示CPVT致心律失常潜力的关键事件。

要点

  • CPVT工程化心肌组织在快速起搏和儿茶酚胺刺激下出现折返心律,再现疾病特征。
  • 该条件下舒张期Ca2+升高、Ca2+波速度时空离散度增加,形成致心律失常基质。
  • CaMKII介导的RyR-Ser2814磷酸化是揭示CPVT组织致心律失常潜力所必需。

核心结论

  • CPVT的组织水平致心律失常机制涉及CaMKII依赖的RyR-Ser2814磷酸化及折返。

研究设计与样本

  • 研究采用光遗传学工程化人类心肌组织模型,由人诱导多能干细胞来源心肌细胞构建,并结合基因组编辑。

主要发现

  • CPVT组织在快速起搏和儿茶酚胺刺激下易发生折返心律,再现疾病标志性特征。
  • 上述条件升高舒张期Ca2+水平并增加Ca2+波速度的时间与空间离散度,形成易损心律失常基质。
  • 通过Cas9基因组编辑确定,Ca2+/钙调蛋白依赖性蛋白激酶II对Ryanodine受体Ser2814的磷酸化是揭示CPVT组织致心律失常潜力所必需的单一起搏酚胺驱动事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Modeling of human arrhythmias with induced pluripotent stem cell-derived cardiomyocytes has focused on single-cell phenotypes. However, arrhythmias are the emergent properties of cells assembled into tissues, and the impact of inherited arrhythmia mutations on tissue-level properties of human heart tissue has not been reported. METHODS: Here, we report an optogenetically based, human engineered tissue model of catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited arrhythmia caused by mutation of the cardiac ryanodine channel and triggered by exercise. We developed a human induced pluripotent stem cell-derived cardiomyocyte-based platform to study the tissue-level properties of engineered human myocardium. We investigated pathogenic mechanisms in CPVT by combining this novel platform with genome editing. RESULTS: In our model, CPVT tissues were vulnerable to developing reentrant rhythms when stimulated by rapid pacing and catecholamine, recapitulating hallmark features of the disease. These conditions elevated diastolic Ca2+ levels and increased temporal and spatial dispersion of Ca2+ wave speed, creating a vulnerable arrhythmia substrate. Using Cas9 genome editing, we pinpointed a single catecholamine-driven phosphorylation event, ryanodine receptor-serine 2814 phosphorylation by Ca2+/calmodulin-dependent protein kinase II, that is required to unmask the arrhythmic potential of CPVT tissues. CONCLUSIONS: Our study illuminates the molecular and cellular pathogenesis of CPVT and reveals a critical role of calmodulin-dependent protein kinase II-dependent reentry in the tissue-scale mechanism of this disease. We anticipate that this approach will be useful for modeling other inherited and acquired cardiac arrhythmias.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Park SJ, Zhang D, Qi Y, et al. Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue. Circulation. 2019. PMID: 31311300. doi:10.1161/CIRCULATIONAHA.119.039711

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。